(Total Views: 304)
Posted On: 06/27/2022 8:16:32 AM
Post# of 65
HERE’S WHY EMERGENT BIOSOLUTIONS IS WORTH INVESTING!
$EBS
Emergent BioSolutions, Inc. (NYSE:EBS), a life sciences company is developing a portfolio of vaccines and therapeutics for urgent health threats, announced the acceptance of a Biologics License Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted) by the U.S. Food and Drug Administration (FDA).
Here's what you need to know before investing in the Company!
https://www.aviseanalytics.com/heres-why-emer...investing/
$EBS
Emergent BioSolutions, Inc. (NYSE:EBS), a life sciences company is developing a portfolio of vaccines and therapeutics for urgent health threats, announced the acceptance of a Biologics License Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted) by the U.S. Food and Drug Administration (FDA).
Here's what you need to know before investing in the Company!
https://www.aviseanalytics.com/heres-why-emer...investing/
(0)
(0)Scroll down for more posts ▼
